Thyroid Diseases: Clinical Trials

18 trials for Thyroid Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 unknown. 18 Phase 3, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 318Unknown 18
Phase 27Unknown 7

Follow Thyroid Diseases: new trials by email Literature Review of Thyroid Diseases trials Research Report on Thyroid Diseases

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short-Term Versus 6-Week Prednisone in The Treatment of Subacute Thyroiditis
1-week predisone+1-week celecoxib, 6-weeks predisone - Subacute Thyroiditis
Phase 3UnknownXinqiao Hospital of Chongqing6002024-04-012024-02-29
Graves' Disease Remission Study: MycoMeth Combo
Mycophenolate Mofetil, Oral, 250 Mg, methimazole, oral, 10mg - Graves' Disease
Phase 2 / Phase 3UnknownThe First Affiliated Hospital of Xiamen University2052023-10-162024-02-28
A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy
Methimazole, Radioiodine or thyroidectomy - Graves' Orbitopathy
Phase 3UnknownUniversity of Pisa522023-03-022023-03-17
Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy
Autofluorescent detection + Injection of indocyanine green, Gold standard of visual identification and evaluation of viability of the parathyroid glands. - Thyroid Disease, Hypoparathyroidism Postprocedural
Phase 3UnknownOnze Lieve Vrouw Hospital3002021-11-012024-04-05
A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease
HBM9161 680 mg qw by q2w from week 13, Placebo, HBM9161 680 mg qw by q2w from week 7 - Thyroid Ophthalmopathy
Phase 2 / Phase 3UnknownHarbour BioMed (Guangzhou) Co. Ltd.362021-09-222022-02-23
Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO
Glucocorticoids - Thyroid Associated Ophthalmopathy
Phase 3UnknownSun Yat-sen University1422021-05-012021-05-18
Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism
Cholestyramine Powder 4g, Prednisolone, Standard treatment - Hyperthyroidism, Graves Disease
Phase 3UnknownClinical Research Centre, Malaysia1352017-05-112017-10-05
Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy
Antithyroid Drug, Total thyroidectomy - Graves Disease, Graves Ophthalmopathy
Phase 3UnknownMedical University of Vienna602017-03-012017-02-28
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
I131, I123 - Thyroid Neoplasms
Phase 2 / Phase 3UnknownNational Cancer Center, Korea5562013-05-012017-01-20
Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy
Prednisone+placebo of Doxycycline, Doxycycline+placebo of Prednisone - Thyroid Associated Opthalmopathies
Phase 2 / Phase 3UnknownSun Yat-sen University1462012-11-012013-12-10
Bupivacaine Injection of Eye Muscles to Treat Strabismus
Bupivacaine - Strabismus, Esotropia
Phase 2 / Phase 3UnknownSmith-Kettlewell Eye Research Institute1202012-04-012019-09-23
Medico-economic Evaluation Comparing the Use of Ultrasonic Scissors to the Conventional Techniques of Haemostasis in Thyroid Surgery by Cervicotomy
Ultrasonic Scissors (Ethicon), Bipolar Electrosurgical instruments (Medtronic) (SLS- Clips) - Thyroid Tumor
Phase 3UnknownNantes University Hospital13502012-03-012014-07-01
Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
Routine central neck dissection - Carcinoma
Phase 2 / Phase 3UnknownSamsung Medical Center20002009-05-012016-04-21
The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions
Iodine 131 - Hypothyroidism, Exophthalmos
Phase 3UnknownSun Yat-sen University6272007-07-012015-05-25
Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients
Thyrogen, thyroid hormone withdrawal, iode 131 - Thyroid Cancer
Phase 3UnknownGustave Roussy, Cancer Campus, Grand Paris9502007-02-012007-02-19
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH - Head and Neck Cancer
Phase 3UnknownUniversity College, London4382006-11-012023-12-19
Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease
Botulinum toxin A injection - Eye Diseases
Phase 2 / Phase 3UnknownShahid Beheshti University of Medical Sciences502005-05-012007-02-27
The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy
Radioactive iodine - Thyroid Neoplasms
Phase 3UnknownUniversity of Helsinki1602000-01-012018-03-02

Narrower conditions

Graves Ophthalmopathy (6)  ·  Graves Disease (4)  ·  Thyroid Neoplasms (4)  ·  Adenocarcinoma, Follicular (1)  ·  Blepharoptosis (1)  ·  Carcinoma (1)  ·  Diplopia (1)  ·  Esotropia (1)  ·  Exophthalmos (1)  ·  Exotropia (1)  ·  Eye Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Hyperthyroidism (1)  ·  Hypothyroidism (1)

Broader conditions

Endocrine System Diseases (18)  ·  Orbital Diseases (10)  ·  Autoimmune Diseases (9)  ·  Exophthalmos (9)  ·  Eye Diseases (9)  ·  Goiter (9)  ·  Immune System Diseases (9)  ·  Hyperthyroidism (8)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Eye Diseases, Hereditary (6)  ·  Genetic Diseases, Inborn (6)  ·  Neoplasms (6)  ·  Endocrine Gland Neoplasms (5)  ·  Graves Disease (5)

Interventions

Iodine-131 (4)  ·  Methimazole (3)  ·  Thyrotropin Alfa (2)  ·  Antithyroid Agents (1)  ·  Botulinum Toxins, Type A (1)  ·  Bupivacaine (1)  ·  Carbimazole (1)  ·  Chlortetracycline (1)  ·  Cholestyramine Resin (1)  ·  Glucocorticoids (1)  ·  HBM9161 (1)  ·  Iodine-123 (1)  ·  Mycophenolic Acid (1)  ·  Prednisolone (1)  ·  Prednisone (1)

Sponsors

Sun Yat-sen University (3)  ·  Clinical Research Centre, Malaysia (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  Harbour BioMed (Guangzhou) Co. Ltd. (1)  ·  Medical University of Vienna (1)  ·  Nantes University Hospital (1)  ·  National Cancer Center, Korea (1)  ·  Onze Lieve Vrouw Hospital (1)  ·  Samsung Medical Center (1)  ·  Shahid Beheshti University of Medical Sciences (1)  ·  Smith-Kettlewell Eye Research Institute (1)  ·  The First Affiliated Hospital of Xiamen University (1)  ·  University College, London (1)  ·  University of Helsinki (1)  ·  University of Pisa (1)

Countries

China (5)  ·  France (2)  ·  South Korea (2)  ·  Austria (1)  ·  Belgium (1)  ·  Finland (1)  ·  Iran (1)  ·  Italy (1)  ·  Malaysia (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Alan B Scott, MD (1)  ·  Babak Babsharif, MD (1)  ·  Dan Liang, MD (1)  ·  Eun Kyung Lee, M.D.,Ph.D. (1)  ·  Fangsen Xiao, MD (1)  ·  Guido Dorner, MD (1)  ·  Huasheng Yang, Doctor (1)  ·  Huifang Zhou (1)  ·  Jee Soo Kim, M.D., Ph.D. (1)  ·  Joel M Miller, PhD (1)  ·  Liya Wang, MD (1)  ·  Luosheng Tang, MD (1)

Results publications

PMID 18382668, PMID 20126486, PMID 22551127, PMID 22551128, PMID 26670972, PMID 27272078, PMID 27521067, PMID 27797318, PMID 29396246, PMID 29807824, PMID 29951599, PMID 30055804, PMID 30501974, PMID 30912336, PMID 32055040, PMID 32616746, PMID 32929476, PMID 34598995, PMID 35223896, PMID 35959915, PMID 36346684

NIH funding

2005 (1), 2015 (1)